| Iron-catalyzed 1, 4-hydroboration of 1, 3-dienes JY Wu, B Moreau, T Ritter Journal of the American Chemical Society 131 (36), 12915-12917, 2009 | 310 | 2009 |
| Expedient synthesis of cyclopropane α-amino acids by the catalytic asymmetric cyclopropanation of alkenes using iodonium ylides derived from methyl nitroacetate B Moreau, AB Charette Journal of the American Chemical Society 127 (51), 18014-18015, 2005 | 207 | 2005 |
| Iron-catalyzed 1, 4-addition of α-olefins to dienes B Moreau, JY Wu, T Ritter Organic Letters 11 (2), 337-339, 2009 | 136 | 2009 |
| Palladium (0)-catalyzed difunctionalization of 1, 3-dienes: from racemic to enantioselective X Wu, LZ Gong Synthesis 51 (01), 122-134, 2019 | 124 | 2019 |
| Targeting the somatostatin receptor 2 with the miniaturized drug conjugate, PEN-221: a potent and novel therapeutic for the treatment of small cell lung cancer KA Whalen, BH White, JM Quinn, K Kriksciukaite, R Alargova, ... Molecular Cancer Therapeutics 18 (11), 1926-1936, 2019 | 55 | 2019 |
| Cobalt-catalyzed hydroboration and borylation of alkenes and alkynes Z Zuo, H Wen, G Liu, Z Huang Synlett 29 (11), 1421-1429, 2018 | 48 | 2018 |
| Discovery of an SSTR2-targeting maytansinoid conjugate (PEN-221) with potent activity in vitro and in vivo BH White, K Whalen, K Kriksciukaite, R Alargova, T Au Yeung, P Bazinet, ... Journal of Medicinal Chemistry 62 (5), 2708-2719, 2019 | 41 | 2019 |
| Discovery of hepatitis C virus NS3-4A protease inhibitors with improved barrier to resistance and favorable liver distribution B Moreau, JA O’Meara, J Bordeleau, M Garneau, C Godbout, V Gorys, ... Journal of Medicinal Chemistry 57 (5), 1770-1776, 2014 | 39 | 2014 |
| Catalytic asymmetric synthesis of nitrocyclopropane carboxylates B Moreau, D Alberico, VNG Lindsay, AB Charette Tetrahedron 68 (17), 3487-3496, 2012 | 39 | 2012 |
| Organo-f-Complexes for Efficient and Selective Hydroborations H Liu, MS Eisen Synthesis 52 (05), 629-644, 2020 | 34 | 2020 |
| Molecular mechanism by which a potent hepatitis C virus NS3-NS4A protease inhibitor overcomes emergence of resistance JA O'Meara, CT Lemke, C Godbout, G Kukolj, L Lagacé, B Moreau, ... Journal of Biological Chemistry 288 (8), 5673-5681, 2013 | 27 | 2013 |
| Xanthates as synthetic equivalents of oxyacyl radicals: access to lactones under tin-free conditions JA Davy, JW Mason, B Moreau, JE Wulff The Journal of Organic Chemistry 77 (14), 6332-6339, 2012 | 25 | 2012 |
| Expedient Stereoselective Synthesis of Coronafacic Acid Through Intramolecular Diels− Alder Cyclization B Moreau, M Ginisty, D Alberico, AB Charette The Journal of Organic Chemistry 72 (4), 1235-1240, 2007 | 24 | 2007 |
| Simple method provides resolution of albumin, lipoprotein, free fraction, and chylomicron to enhance the utility of protein binding assays AH Brockman, HR Oller, B Moreau, K Kriksciukaite, MT Bilodeau Journal of Medicinal Chemistry 58 (3), 1420-1425, 2015 | 11 | 2015 |
| A symmetry-driven approach to the putative spiroketal core of the didemnaketals JA Davy, B Moreau, AG Oliver, JE Wulff Tetrahedron 71 (18), 2643-2657, 2015 | 10 | 2015 |
| Activation strategies for earth-abundant metal catalysis J Peng, SP Thomas Synlett 31 (12), 1140-1146, 2020 | 9 | 2020 |
| New Synthetic Methodology Toward Azaspiro-γ-Lactones by Oxidative C–H Spirocyclization T Sengoku, Y Nagai, T Inuzuka, H Yoda Synlett 30 (02), 199-202, 2019 | 9 | 2019 |
| Synergistic Catalysis for Stereodivergent Synthesis of trans-and cis-Skipped Dienes F Wang, S Zhu, L Chu Synlett 31 (18), 1741-1746, 2020 | 6 | 2020 |
| Novel miniaturized drug conjugate leverages HSP90-driven tumor accumulation to overcome PI3K inhibitor delivery challenges to solid tumors S Perino, B Moreau, J Freda, A Cirello, BH White, JM Quinn, ... Molecular Cancer Therapeutics 19 (8), 1613-1622, 2020 | 6 | 2020 |
| BTP-114: An albumin binding cisplatin prodrug with improved and sustained tumor growth inhibition B Moreau, R Alargova, A Brockman, K Whalen, J Quinn, K Meetze, ... Cancer Research 75 (15_Supplement), 4484-4484, 2015 | 6 | 2015 |
